Foreign media: China is advancing the "Health Silk Road" in Africa, filling local drug production gaps by launching major pharmaceutical projects in Africa. For example, Nigeria will produce insulin under Chinese brands, and Shanghai Fosun Pharma's project in Côte d'Ivoire is scheduled to complete the first phase of its 50 million euro (about 58 million US dollars) factory by the end of this year. The factory will produce antimalarial and antibacterial drugs.
Africa accounts for a quarter of the global disease burden, but most of its vaccines and 70% of essential medicines depend on imports. The involvement of Chinese enterprises aims to meet the high demand in Africa for generic drugs and chronic disease treatment medications.
Original article: www.toutiao.com/article/1845693244482560/
Statement: This article represents the personal views of the author.